News tagged with journal of clinical oncology

70-gene signature not cost-effective in breast cancer

(HealthDay)—For patients with node-negative breast cancer (NNBC), the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making, according to a study published ...

Oct 18, 2014
popularity 3 / 5 (2) | comments 0